Increasing the antitumor efficacy of doxorubicin-loaded liposomes with peptides anchored via a chelator lipid.
about
A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or densityRecent trends in multifunctional liposomal nanocarriers for enhanced tumor targetingPeptide targeted lipid nanoparticles for anticancer drug delivery.Ligation strategies for targeting liposomal nanocarriers.A bioanalytical assay to distinguish cellular uptake routes for liposomes.Biotin-conjugated fusogenic liposomes for high-quality cell purification.
P2860
Increasing the antitumor efficacy of doxorubicin-loaded liposomes with peptides anchored via a chelator lipid.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Increasing the antitumor effic ...... anchored via a chelator lipid.
@en
Increasing the antitumor effic ...... anchored via a chelator lipid.
@nl
type
label
Increasing the antitumor effic ...... anchored via a chelator lipid.
@en
Increasing the antitumor effic ...... anchored via a chelator lipid.
@nl
prefLabel
Increasing the antitumor effic ...... anchored via a chelator lipid.
@en
Increasing the antitumor effic ...... anchored via a chelator lipid.
@nl
P2860
P1476
Increasing the antitumor effic ...... anchored via a chelator lipid.
@en
P2093
Joseph G Altin
Thomas P Herringson
P2860
P304
P356
10.3109/1061186X.2010.536984
P577
2010-12-09T00:00:00Z